Eleftheria Galatou, Elena Mourelatou, Sophia Hatziantoniou, & Ioannis S. Vizirianakis. (2022). Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs. MDPI AG.
Chicago Style (17th ed.) CitationEleftheria Galatou, Elena Mourelatou, Sophia Hatziantoniou, and Ioannis S. Vizirianakis. Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs. MDPI AG, 2022.
MLA (9th ed.) CitationEleftheria Galatou, et al. Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.